Found 6 matching trials
A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Intermediate to High Risk Myelofibrosis PHASE2 This trial adopts a single arm, open label, multi center clinical trial des...
Show More Location
West China Hospital Sichuan University
Learn More & Join Trial
Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors PHASE1 Flonoltinib Maleate (FM) targets Janus kinase 2 (JAK2) and FMS-like tyrosin...
Show More Location
Multiple Locations
Learn More & Join Trial
Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis PHASE2 The goal of this clinical trial is to learn which of three different doses ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis PHASE2 This trial adopts a multicenter, open-label, positive drug parallel control...
Show More Status
Active Not Recruiting
Location
West China Hospital Sichuan University
Learn More & Join Trial
Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative PHASE1 Flonoltinib Maleate (FM) targets Janus kinase 2 (JAK2) and FMS-like tyrosin...
Show More Location
West China Hospital Sichuan University
Learn More & Join Trial
A Phase I Clinical Study of Flonoltinib Maleate Tablets in Healthy Subjects PHASE1 Evaluate the safety , tolerability and pharmacokinetics of Flonoltinib Male...
Show More Location
Chengdu Xinhua Hospital
Learn More & Join Trial